Delayed hypersensitivity skin test for tuberculin purified protein derivative- PPD

The delayed hypersensitivity skin test for tuberculin purified protein derivative (PPD) is a diagnostic procedure rather than a primary disease, utilized to detect cell-mediated immune sensitization to *Mycobacterium tuberculosis* in pediatric and adult populations

The delayed hypersensitivity skin test for tuberculin purified protein derivative (PPD) is a diagnostic procedure rather than a primary disease, utilized to detect cell-mediated immune sensitization to *Mycobacterium tuberculosis* in pediatric and adult populations It identifies individuals with latent tuberculosis infection or active tuberculosis disease, particularly those at elevated risk due to known exposure, immunosuppression, or occupational setting Pathophysiologically, intradermal admin...

The delayed hypersensitivity skin test for tuberculin purified protein derivative (PPD) is a diagnostic procedure rather than a primary disease, utilized to detect cell-mediated immune sensitization to *Mycobacterium tuberculosis* in pediatric and adult populations It identifies individuals with latent tuberculosis infection or active tuberculosis disease, particularly those at elevated risk due to known exposure, immunosuppression, or occupational setting

It identifies individuals with latent tuberculosis infection or active tuberculosis disease, particularly those at elevated risk due to known exposure, immunosuppression, or occupational setting This cell-mediated response typically manifests clinically as a palpable cutaneous induration that reaches peak intensity and is quantitatively measured between 48 and 72 hours post-injection

Pathophysiologically, intradermal administration of PPD elicits a type IV delayed-type hypersensitivity reaction in previously sensitized individuals, wherein memory T lymphocytes recruit mononuclear cells and cause local vasodilation and edema This cell-mediated response typically manifests clinically as a palpable cutaneous induration that reaches peak intensity and is quantitatively measured between 48 and 72 hours post-injection

Pathophysiologically, intradermal administration of PPD elicits a type IV delayed-type hypersensitivity reaction in previously sensitized individuals, wherein memory T lymphocytes recruit mononuclear cells and cause local vasodilation and edema